Finance

Lists
COYA:NASDAQ
Coya Therapeutics Inc
4,81 $
+1,69%
(+0,080) 1D
5,06 $
+5,20% (+0,25)
Pre-market
Closed: 2 հոկ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for COYA...
Open
4,80 $
High
4,93 $
Low
4,76 $
Mkt. cap
112,83 մլն
Avg. vol.
130,47 հզր
Volume
100,00
52-wk high
7,75 $
52-wk low
3,71 $
EPS
-1,07 $
Beta
0,58
Shares outstanding
23,46 մլն
No. of employees
8
Open
4,80 $
High
4,93 $
Low
4,76 $
Mkt. cap
112,83 մլն
Avg. vol.
130,47 հզր
Volume
100,00
52-wk high
7,75 $
52-wk low
3,71 $
EPS
-1,07 $
Beta
0,58
Shares outstanding
23,46 մլն
No. of employees
8
News stories
From web sources and news partners
About Coya Therapeutics Inc
CEO-
Employees8
Founded2020
HeadquartersՀյուստոն, Տեխաս, Միացյալ Նահանգներ
Sector-
Websitecoyatherapeutics.com
Analyst ratings
Based on 3 analysts giving stock ratings to COYA in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for COYA in the last 3 months.
Highest
Current 4,81 $
18,00 $ (+274,22%)
Average
15,33 $ (+218,71%)
Lowest
12,00 $ (+149,48%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
18,00 $
+274,2%
09/25/2026
Boobalan Pachaiyappan
Roth MKM
Buy
Reiterated
12,00 $
+149,5%
08/23/2026
Thomas Shrader
BTIG
Buy
Maintained
16,00 $
+232,6%
08/11/2026
Chad Messer
Lake Street
Buy
Maintained
17,00 $
+253,4%
05/22/2026
Keay Nakae
Chardan Capital
Buy
Maintained
14,00 $
+191,1%
05/12/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
3,56 մլն
3,96 մլն
251,15 հզր
243,74 հզր
Cost of goods sold
2,92 մլն
4,94 մլն
4,10 մլն
5,03 մլն
Cost of revenue
2,92 մլն
4,94 մլն
4,10 մլն
5,03 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,56 մլն
3,27 մլն
3,78 մլն
2,26 մլն
Operating expense
2,56 մլն
3,28 մլն
3,78 մլն
2,26 մլն
Total operating expenses
5,48 մլն
8,22 մլն
7,88 մլն
7,29 մլն
Operating income
-1,92 մլն
-4,26 մլն
-7,63 մլն
-7,05 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-2,12 մլն
-5,71 մլն
-7,21 մլն
-6,64 մլն
EBT excluding unusual items
-1,60 մլն
-3,93 մլն
-7,20 մլն
-6,64 մլն
Income tax expense
-
3,09 հզր
-
-
Effective tax rate
-
-0,05%
-
-
Other operating expenses
-
-
-
-
Net income
-2,12 մլն
-5,71 մլն
-7,21 մլն
-6,64 մլն
Net profit margin
-59,36%
-144,16%
-2 869,63%
-2 723,44%
Earnings per share
-0,13
-0,34
-0,32
-0,28
Interest and investment income
317,07 հզր
325,44 հզր
433,23 հզր
408,73 հզր
Interest expense
-
-
-
-
Net interest expenses
317,07 հզր
325,44 հզր
433,23 հզր
408,73 հզր
Depreciation and amortization charges
6,84 հզր
6,84 հզր
2,81 հզր
2,81 հզր
EBITDA
-1,91 մլն
-4,25 մլն
-7,63 մլն
-7,04 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps